Jiangyin, China · Founded 2009 · In IPO Registration
Developer and manufacturer of novel antimicrobial peptide drugs and therapeutic candidates designed for drug-resistant infections, metabolic disorders, and autoimmune diseases. Protelight Pharmaceuticals is based in Jiangyin, China and was founded in 2009. Its last reported valuation was $352 million in Nov 2025. It has raised $115 million.
Last reported valuation
$351.9M
Oct 2026
Priced at
—
Total raised
$115.0M
Last round
—
Cap table — not yet on record
Protelight Pharmaceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Protelight Pharmaceuticals with a free account
·The complete investor list: 12 names
·Watch Protelight Pharmaceuticals: the Monday email on marks, rounds and moves
